![Robert E. Winkler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Robert E. Winkler
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 6 | |
Public Company | Biotechnology | 4 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Robert E. Winkler via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | General Counsel | |
EMC CORPORATION | Computer Peripherals | Human Resources Officer | |
GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member | |
Rochester Christian University | College/University | Undergraduate Degree | |
Goldman Sachs International
![]() Goldman Sachs International Investment Banks/BrokersFinance Goldman Sachs International (GSI) is the Great Britain-based, wholly-owned brokerage subsidiary of Goldman Sachs Group UK Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm was founded in 1988 and formerly known as Trushelfco Ltd. Headquartered in London, GSI provides prime brokerage, securities lending, futures services and financing services for a range of clients such as corporations, financial institutions, governments and high-net worth individuals. | Investment Banks/Brokers | Analyst-Equity | |
INSMED INCORPORATED | Pharmaceuticals: Major | Human Resources Officer | |
SEAGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Anchorage Capital Group LLC
![]() Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group LLC is a SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Kevin Ulrich in 2003 as Anchorage Advisors LLC. They are a subsidiary of Anchorage Advisors Management LLC. Anchorage Capital Group provides investment advisory services to private investment funds and structured credit vehicles. | Investment Managers | Director/Board Member | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Biotechnology Innovation Organization
![]() Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Chairman | |
CureVac SE
![]() CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Corporate Officer/Principal | |
Presage Biosciences, Inc.
![]() Presage Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Presage Biosciences, Inc. engages in development of novel drugs for treatment of cancers. It offers CIVO arrayed microinjection platform that allows for simultaneous assessment of multiple drugs or drug combinations directly in a single solid tumor while still in a patient’s body to assess efficacy, resistance, and drug synergies in the tumor’s native microenvironment. The company was founded by James M. Olson and Thane Kreiner in 2008 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chairman | |
AURA BIOSCIENCES, INC. | Biotechnology | Chairman | |
ROIVANT SCIENCES LTD. | Pharmaceuticals: Major | Director/Board Member | |
University of Virginia | College/University | Undergraduate Degree | |
Goldman Sachs & Co. LLC
![]() Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Investment Banks/Brokers | Analyst-Equity | |
Boston University | College/University | Masters Business Admin | |
BLUEBIRD BIO, INC. | Biotechnology | Director of Finance/CFO | |
Eisai, Inc.
![]() Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Flagship Pioneering
![]() Flagship Pioneering Investment ManagersFinance Flagship Pioneering (Flagship Pioneering) is a venture capital firm founded in 1982 by Ed M Kania and Noubar B Afeyan. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Human Resources Officer | |
Indiana University | College/University | Undergraduate Degree | |
Universität zu Köln | College/University | Doctorate Degree | |
The Hebrew University of Jerusalem | College/University | Undergraduate Degree | |
Akamis Bio Ltd.
![]() Akamis Bio Ltd. BiotechnologyHealth Technology Akamis Bio Ltd. operates as a biotechnology company which develops novel therapeutics that addresses cancer and other clinically unmet diseases. Its products include Enadenotucirev, Espindolol and AbEnAd. The firm also develops treatments based upon the research phase vaccine platform PolySTAR, which combines recombinant viral vectors with polymers to shield them from the immune system, and the research phase adjuvant and immunotherapeutic platform PolyMAP, which combines polymers with synthetic adjuvants to significantly enhance the effectiveness of vaccines. The company was founded by Andrew Justin Stewart Coats and Stefan D. Anker on November 17, 2006 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Director of Finance/CFO | |
Avillion LLP
![]() Avillion LLP Pharmaceuticals: MajorHealth Technology Avillion LLP operates as a drug development company that focuses on clinical development and approval of late stage pharmaceutical products and candidates. It offers global clinical trial, and global regulatory services. The firm serves pharmaceutical and biotechnology companies. The company was founded in 2012 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Acerta Pharma BV
![]() Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Chief Executive Officer | |
Theravance Biopharma US, Inc.
![]() Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin | |
Yale School of Medicine | College/University | Doctorate Degree | |
Deep Genomics, Inc.
![]() Deep Genomics, Inc. BiotechnologyHealth Technology Deep Genomics, Inc. provides machine learning, genome biology and precision medicine. It develops an integrated computational system that could learn, predict, and interpret how genetic variation, whether natural or therapeutic, alters crucial cellular processes. The firm offers SPIDEX database, which is a set of genetic variants and their predicted effects on human splicing across the entire genome. Its SPIDEX database covers all synonymous, missense, and nonsense exonic SNVs, as well as intronic SNVs that are up to 300nt from splice junctions. The company was founded by Brendan Frey and Hui Yuan Xiong in 2015 and is headquartered in Toronto, Canada. | Biotechnology | Chairman | |
Oncternal Oncology, Inc.
![]() Oncternal Oncology, Inc. Pharmaceuticals: MajorHealth Technology Oncternal Oncology, Inc. is a clinical-stage oncology company, which engages in the development of novel therapies for both rare and common cancers. The company was founded by Lauren Otsuki and Cam L. Garner and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman | |
R-Pharm US LLC
![]() R-Pharm US LLC Pharmaceuticals: MajorHealth Technology R-Pharm US LLC engages in development and commercialization of medicines to treat cancer. Its products include IXEMPRA and episil. The company was founded by Mark Pavao and Demetrios Kydonieus in 2014 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
Palleon Pharmaceuticals, Inc.
![]() Palleon Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Palleon Pharmaceuticals, Inc. operates as biotechnology company. The firm discovers and develops immuno-oncology drugs, medicines, and therapies for the treatment of cancer diseases. It specializes in clinical development, and glyco-immune checkpoint inhibitors. The company was founded by Jim Broderick, Carolyn Bertozzi and Paul Crocker in 2015 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
KINNATE BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Lengo Therapeutics, Inc.
![]() Lengo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Lengo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Chairman | |
STRUCTURE THERAPEUTICS INC. | Miscellaneous Commercial Services | Director/Board Member | |
Nautilus Subsidiary, Inc.
![]() Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Nautilus Biotechnology, Inc. operates as a biopharmaceutical company. The company was founded by Sujal Patel and Parag Mallick in 2016 and is headquartered in San Carlos, CA. | Information Technology Services | Director/Board Member | |
ROYALTY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
Life Science Cares Bay Area | Director/Board Member | ||
2SEVENTY BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
NAUTILUS BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member | |
GLOBAL BLOOD THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Solve Therapeutics, Inc.
![]() Solve Therapeutics, Inc. BiotechnologyHealth Technology Solve Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops novel antibody-based therapies targeting tumor-specific antigens. The company is based in Belmont, CA, and has subsidiaries in the United States. The company's formation has reunited members of the former VelosBio Inc. team, a highly experienced group with a proven ability to rapidly advance innovative therapeutics that address unmet medical needs in the treatment of cancer. Solvetx has been actively pursuing discovery and development efforts at its state-of-the-art laboratory facilities. The company has licensed or generated targeting antibodies and nanobodies with ideal characteristics to serve as the backbones for antibody-based therapeutics and has rights to technology supporting the development of diagnostic and therapeutic antibody-radionuclide conjugates (ARCs). Solvetx is supported by a syndicate of sophisticated healthcare investors, including Ayurmaya Capital Management Fund (an affiliate of Matrix Capital Management), Decheng Capital, General, and Surveyor Capital (a Citadel company). The company was founded by David M. Johnson and has been led by him as the CEO since incorporation. | Biotechnology | Founder | |
The Andalusia Foundation | Director/Board Member |
Statistieken
Internationaal
Verenigde Staten | 40 |
Verenigd Koninkrijk | 5 |
Duitsland | 4 |
Israël | 2 |
China | 2 |
Sectoraal
Health Technology | 28 |
Consumer Services | 9 |
Commercial Services | 6 |
Finance | 5 |
Electronic Technology | 3 |
Operationeel
Director/Board Member | 55 |
Independent Dir/Board Member | 24 |
Corporate Officer/Principal | 20 |
Chairman | 14 |
Chief Executive Officer | 9 |
Sterkste connecties
Insiders | |
---|---|
Ted Love | 31 |
Robert Essner | 23 |
Melissa Epperly | 13 |
Pol Boudes | 12 |
David Johnson | 11 |
Chip Baird | 10 |
Geoffrey Gilmore | 9 |
S. Schaeffer | 7 |
Dimitris Voliotis | 5 |
Orna Bornstein | 4 |
- Beurs
- Insiders
- Robert E. Winkler
- Bedrijfsconnecties